Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stone

Showing results (1121-1130 of 1,488) with videos related to

Pageof 149
Sort By:
Rheumatology (Oxford, England)|October 31, 2021
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extensionJohn H Stone, Helen Spotswood, Sebastian H Unizony, et al.
Circulation|March 1, 1989
Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery diseaseS N Willich, S Pohjola-Sintonen, S J Bhatia, et al.
Seminars in Arthritis and Rheumatism|April 29, 2022
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over timeJohn H Stone, P Jane McDowell, David R W Jayne, et al.
Circulation|October 24, 2001
Depression, heart rate variability, and acute myocardial infarctionR M Carney, J A Blumenthal, P K Stein, et al.
Seminars in Arthritis and Rheumatism|December 22, 2016
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trialKatie Tuckwell, Neil Collinson, Sophie Dimonaco, et al.
Circulation|April 1, 1984
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparisonJ E Muller, J Morrison, P H Stone, et al.
Journal of Occupational and Environmental Medicine|November 14, 2006
Personal coronary risk profiles modify autonomic nervous system responses to air pollutionJiu-Chiuan Chen, Peter H Stone, Richard L Verrier, et al.
Annals of the Rheumatic Diseases|February 11, 2015
Rituximab for IgG4-related disease: a prospective, open-label trialMollie N Carruthers, Mark D Topazian, Arezou Khosroshahi, et al.
Annals of Internal Medicine|May 2, 2007
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trialGary S Hoffman, Maria C Cid, Karen E Rendt-Zagar, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 23, 2014
How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stressIoannis Andreou, Antonios P Antoniadis, Koki Shishido, et al.
Pageof 149

Showing results (1121-1130 of 1,488) with videos related to

Sort By:
Pageof 149
Rheumatology (Oxford, England)|October 31, 2021
New-onset versus relapsing giant cell arteritis treated with tocilizumab: 3-year results from a randomized controlled trial and extensionJohn H Stone, Helen Spotswood, Sebastian H Unizony, et al.
Circulation|March 1, 1989
Suppression of silent ischemia by metoprolol without alteration of morning increase of platelet aggregability in patients with stable coronary artery diseaseS N Willich, S Pohjola-Sintonen, S J Bhatia, et al.
Seminars in Arthritis and Rheumatism|April 29, 2022
The glucocorticoid toxicity index: Measuring change in glucocorticoid toxicity over timeJohn H Stone, P Jane McDowell, David R W Jayne, et al.
Circulation|October 24, 2001
Depression, heart rate variability, and acute myocardial infarctionR M Carney, J A Blumenthal, P K Stein, et al.
Seminars in Arthritis and Rheumatism|December 22, 2016
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trialKatie Tuckwell, Neil Collinson, Sophie Dimonaco, et al.
Circulation|April 1, 1984
Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparisonJ E Muller, J Morrison, P H Stone, et al.
Journal of Occupational and Environmental Medicine|November 14, 2006
Personal coronary risk profiles modify autonomic nervous system responses to air pollutionJiu-Chiuan Chen, Peter H Stone, Richard L Verrier, et al.
Annals of the Rheumatic Diseases|February 11, 2015
Rituximab for IgG4-related disease: a prospective, open-label trialMollie N Carruthers, Mark D Topazian, Arezou Khosroshahi, et al.
Annals of Internal Medicine|May 2, 2007
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trialGary S Hoffman, Maria C Cid, Karen E Rendt-Zagar, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|October 23, 2014
How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stressIoannis Andreou, Antonios P Antoniadis, Koki Shishido, et al.
Pageof 149